Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactolevure for H. pylori Eradication Side Effects
NCT04178187Completed
- Sponsor
- Evangelismos Hospital
- Start
- Oct 2019
- Primary completion
- Dec 2021
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Randomised, double-blind trial in Helicobacter pylori infection comparing Lactolevure with Placebo (2 arms). Primary endpoint: Prevention of antibiotic side effects at 1 year. Started Oct 2019; status: completed.
02
Drugs
Lactolevure
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT04178187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04178187.